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Abstract: Formation of magnetite nanocrystals by magneto-
tactic bacteria is controlled by specific proteins which regu-
late the particles’ nucleation and growth. One such protein
is Mms6. This small, amphiphilic protein can self-assemble
and bind ferric ions to aid in magnetite formation. To under-
stand the role of Mms6 during in vitro iron oxide precipita-
tion we have performed in situ pH titrations. We find Mms6
has little effect during ferric salt precipitation, but exerts
greatest influence during the incorporation of ferrous ions
and conversion of this salt to mixed-valence iron minerals,
suggesting Mms6 has a hitherto unrecorded ferrous iron in-
teracting property which promotes the formation of mag-
netite in ferrous-rich solutions. We show ferrous binding to
the DEEVE motif within the C-terminal region of Mms6 by
NMR spectroscopy, and model these binding events using
molecular simulations. We conclude that Mms6 functions as
a magnetite nucleating protein under conditions where fer-
rous ions predominate.
Introduction
Essential to many organisms, iron is an important component
of many biological processes.[1] Due to the inherent redox ac-
tivity and pH sensitivity of this transition metal its presence in
cells must be carefully controlled to prevent potentially harm-
ful effects from reactive oxygen species[1c] or iron precipita-
tion.[2] Many proteins have therefore evolved to utilise, control
and harness the useful capabilities of iron whilst minimizing
any potentially damaging side effects.[1a,b] In the case of mag-
netotactic bacteria (MTB), they have evolved to take advantage
of the magnetic characteristics of certain iron oxides by pro-
ducing biogenic magnetic nanoparticles[3] within internal lipid
vesicles termed magnetosomes.[4] These vesicles are in effect
a nanoreactor for the precise synthesis of, most commonly, the
iron oxide magnetite (Fe3O4).
[3c, 5] The formation of nanocrystal-
line magnetite is tightly controlled by a suite of biomineralisa-
tion proteins which are present within the lipid membrane of
the magnetosome.[6] The nucleation, crystal growth and regula-
tion of the final size and shape of the particle are strictly regu-
lated by these proteins. A single strain of MTB harbours
a highly uniform population of nanoparticles; homogeneous in
terms of size, shape, and chemical composition. Research is
currently focusing on identifying and characterising these bio-
mineralisation Mms (magnetosome membrane specific) pro-
teins in order to elucidate a detailed understanding of iron
oxide biomineralisation.
One key protein found tightly bound to the magnetite parti-
cles of Magnetospirillum magneticum AMB-1[7] is a 6 kDa pro-
tein, Mms6. Mms6 comprises a hydrophobic N-terminal region
and a hydrophilic C-terminal region (KSRDIESAQSDEEVELRDA-
Figure 1. Mms6 in magnetotactic bacterial magnetosome. In blue is the hy-
drophilic acid-rich region and in pink is the hydrophobic membrane region
with the sequence below. Experimental schematic showing pH recording
during addition of base to ferric/ferrous solution with or without Mms6 mi-
celles is also illustrated.
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LA) which contains a high number of residues with acidic side-
chains that have been implicated in the ferric iron binding ca-
pability of the protein (Figure 1).[7, 8] If the mms6 gene is re-
moved from MTB (so Mms6 protein is not produced) the re-
sulting nanoparticles which form are both small and poorly
formed compared to the wild-type.[9] Mms6 has therefore been
classified as an important member of the magnetite biominer-
alisation mechanism. Due to its amphiphilic sequence, purified
Mms6 self-assembles into micellar structures.[8a] These large ag-
gregates are able to both bind and accumulate ferric ions from
solution,[7, 8, 10] and purified assemblies of Mms6 on a biomimetic
magnetosome interior surface demonstrate magnetite forma-
tion properties, indicating that Mms6 can act as a potential
iron oxide nucleation site for subsequent crystal formation.[11]
In addition, the acid rich C-terminal part of Mms6 has been
studied and was found to exhibit some similar characteristics
to the full-length protein such as iron binding and a limited
ability to affect magnetite crystal growth.[8a,10,12]
Magnetic nanoparticles have received much attention due
to their potential use in a wide range of different applications
spanning various scientific disciplines and technologies.[13]
These range from the magnetic components of ferrofluids[14]
and data-storage devices, to precision applications in medical
diagnostics and therapies.[15] For this latter use, magnetite is
one of the most desirable materials due to its magnetic prop-
erties and general low toxicity.[15a] There are a number of syn-
thetic routes for magnetite nanoparticles including thermal de-
composition, and high temperature methods in the presence
of organic surfactants.[16] An alternative and simple method of
producing magnetite nanoparticles is by room temperature
co-precipitation (RTCP). This results in particles with a high size
polydispersity making them unsuitable for critical biomedical
applications. Taking inspiration from nature where MTB synthe-
size magnetite nanoparticles with a high degree of control
over size and shape, purified Mms6 has been introduced into
RTCP and other reactions.[7, 17] The resulting products demon-
strate improved homogeneity in both size and mineral type,
suggesting that Mms6 is able to control the formation of mag-
netite nanoparticles in vitro.[7, 17, 18] However, the exact mecha-
nism by which Mms6 achieves this type of control both in vivo
and in vitro remains poorly understood.
In this study we analyse the effect of Mms6 during a simple
RTCP of magnetite by monitoring differences in the pH profile
during the reaction process. This was performed under a range
of different reaction conditions to build up a rigorous and de-
tailed picture of Mms6 activity at different ratios of ferric and
ferrous iron. A previous study of iron oxide formation using
this approach[19] has provided a methodology by which to in-
vestigate the effect of these additives on the crystallisation
process. We find that Mms6 exerts its greatest influence over
the process in the pH range where ferrous ions are precipitat-
ed out of solution (>pH 7). Previous studies have shown that
Mms6 interacts with ferric iron but there is, to the best of our
knowledge, currently no analysis of any potential interaction
with ferrous iron. Therefore, to complement our study we have
used 2D NMR spectroscopy to investigate the ferrous-binding
activity of the C-terminal peptide region of Mms6, which re-
veals that the peptide has specific interactions with ferrous
iron centred around the DEEVE acidic residue cluster. Further
insight is gained through molecular dynamics simulations of
this cluster and its interactions with both ferric and ferrous
iron. This study therefore provides a new perspective on the
activity of the Mms6 protein by suggesting it is interacting
with both ferric and ferrous iron during the magnetite crystalli-
sation process, and that it is the predominant and specific in-
teraction with ferrous iron that is the key to driving the reac-
tion towards magnetite. This finding has implications for our
understanding of magnetite biomineralisation and how we can
control magnetite formation in biomimetic magnetic nanopar-
ticle synthesis for wider nanotechnology applications.
Results
Room temperature co-precipitation of magnetite (RTCP)
The precipitation of iron oxides from solution is complex[20]
and proceeds through a number of intermediate iron oxides. A
comprehensive study of the co-precipitation of ferric and fer-
rous salts by Ruby et al.[19,21] employed careful pH titration
measurements to identify processes occurring during precipita-
tion reactions. The quantities of Mms6 protein available mean
we must use much lower concentrations and reaction volumes
than those used by Ruby et al. which makes the experiment
very sensitive. In this study we use a similar titration method
to monitor the progress of the reaction and the nature of the
intermediates formed both with and without the addition of
Mms6. This allows us to understand if, and how, the protein af-
fects the co-precipitation process and to explain how Mms6 is
able to exert control over the size and the mineral species
formed, specifically magnetite, when added to a RTCP reac-
tion.[12]
Here, a solution of mixed valence iron salts is precipitated
by slowly raising the pH with the addition of base. There are
a number of reactions present in this system[19b] that can lead
to several iron oxide and iron oxyhydroxide products or inter-
mediates, namely the mixed ferric/ferrous minerals magnetite
(Fe2+Fe3+2O4) [Eq. (3)] and green rusts ([Fe
2+
4Fe
3+
2(OH)12]
[SO4]·xH2O [Eq. (2)] as well as the pure ferrous mineral ferrous
hydroxide (Fe2+(OH)2) [Eq. (1)] and pure ferric minerals
schwertmannite ([Fe3+8O8(OH)6] [SO4]·xH2O [Eq. (5)] and goe-
thite (Fe3+O(OH)) [Eq. (4)] at the extremes of the oxidation
states, see Equations (1)–(5), from pure ferrous to pure ferric
minerals:
Fe2þ þ 2OH@ ! FeðOHÞ2 ð1Þ
4 Fe2þ þ 2 Fe3þ þ 12OH@ þ SO42@ ! FeII4FeIII2ðOHÞ12SO4 ð2Þ
Fe2þ þ 2 Fe3þ þ 8OH@ ! FeIIFeIII2O4 þ 4H2O ð3Þ
Fe3þ þ 3OH@ ! FeOOHþ 2H2O ð4Þ
Fe3þ þ ½3@2 zAOH@ þ z SO42@ ! FeOðOHÞ½1@2 zAðSO4Þz2½1@zAH2O
ð5Þ
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Figure 2a shows titration curves for the co-precipitation of
ferric and ferrous iron sulfates with NaOH in the absence of
Mms6. The molar ratio of Fe3+ to total iron is represented by X
(e.g. , Fe3+/Fe2+ ratio of 1:2 gives X=0.33) and ranges from 0
to 1. R is the molar ratio between the concentration of NaOH
and total iron. For these experiments an effective rate of
0.05 Rmin@1 was used for the addition of base, meaning that
in our experiments R increases linearly with time.
The step titration curves shown in Figure 2 have three pla-
teaus separated by two steps defined by the equivalence
points E1 (step between plateaus 1 and 2, shown by circles in
Figure 2) and E2 (step between plateaus 2 and 3, shown by
crosses in Figure 2). E* is defined as the central point of the
second plateau (shown by an asterisk in Figure 2a).
At the lowest pH conditions the first plateau describes OH@
consumption through precipitation of ferric basic salts [e.g. ,
the ferric oxyhydroxide, schwertmannite; Eq. (5)] due to the
lower solubility of ferric ions in the presence of base. The
middle plateau corresponds to the conversion to, and forma-
tion of, a range of possible iron minerals : ferrous hydroxide,
green rust, magnetite and goethite [Eqs. (1)–(4)] in various pro-
portions, increasing in amounts of the latter minerals as the
ratio of ferric to ferrous ions increases (Figure 2). Interestingly,
the ferric oxyhydroxide begins to convert into green rust and
magnetite by incorporation of ferrous ions and through elec-
tron transfer. Once all the ferric solids have been converted,
the excess ferrous ions precipitate as ferrous hydroxide.[19b]
These mixed oxides are retained up to the end of the titration
at pH 12.5. At this point the reaction mixture has a highly neg-
ative redox potential (approximately @750 mV; see Supporting
Information Figure S1) demonstrating its high propensity to
oxidise. If left to age, overnight, with a small amount of oxida-
tion, mineral dehydration can occur, converting other iron
oxides such as green rust (which can be considered as inter-
mediates) to magnetite. The dark green solution becomes
black.
Using the methodology and nomenclature of Ruby et al.[19a]
we plotted the positions of equivalence points derived from
the pH titration data on a mass-balance diagram of R versus X
(Figure 2b). The first equivalence points at E1 lie along the line
R1=2.75X. This represents the theoretical relationship for the
formation of the sulfated ferric oxyhydroxide schwertmannite,
in the first plateau [see Eq. (5), balanced for z=1/8, thus OH/Fe
ratio=2.75:1].[19a] The relative quantity of base (R) required is
linearly dependent on the ratio of ferric/ferrous species (in-
creasing as Fe3+ increases; Figure 2a and b) due to the fact
that there are increasing quantities of ferric iron to precipitate.
The second equivalence point, E2, describes the nature and
proportions of insoluble iron oxides that are formed in the
second plateau (depending on the initial X ratio). As discussed
above, this could be a mixture of green rusts, magnetite and
other ferrous/ferric hydroxide nanoparticles (Supporting Infor-
mation Figure S2 shows products of the reaction at X=0.3 and
0.5 showing a combination of green rust and magnetite at
lower X ratio, and more pure magnetite at the higher). Stoi-
chiometric magnetite would be formed at X=0.67 (i.e. , 2Fe3+
/1Fe2+). However, it should be noted that extracting a vertical
line from the initial X ratio to the products is a simplistic repre-
sentation of the reaction. This reaction has a maturation step
after the titration where a small amount of oxidation occurs
slowly, overnight, to form the most stable products, resulting
in a non-vertical conversion to the most stable products after
this E2 point. In practice, many magnetite nanoparticle synthe-
sis schemes report higher starting ratios of Fe2+ with 0.33,
X,0.6667, in recognition of partial oxidation in the final
stages of the process.[7, 17] Generally, increasing the amount of
Fe2+ in solution results in lower quantities of magnetite and
higher quantities of ferrous (oxy)hydroxide particles, while too
high a quantity of Fe3+ will result in ferric (oxy)hydroxide such
as goethite. In summary, the titrations shown in Figure 2 dem-
onstrate the expected pH-dependent formation of ferrous hy-
droxide, green rusts and magnetite, as well as the information
to understand how and when these are forming and in what
quantities.
Influence of Mms6 on ferrous iron components during the
co-precipitation of magnetite
Previous reports support the finding that mixed iron oxide
populations are often obtained for RTCP. This is seen for exam-
ple in the control sample TEM images presented in Amemiya
et al.[17a] However, in the presence of Mms6, Amemiya et al.
Figure 2. a) pH measurements during room temperature co-precipitation for
total iron concentrations of 50 mm at a rate of 0.05 Rmin@1 with equivalence
points highlighted by circles (E1) and crosses (E2). The central equivalence
point is marked by an asterisk (E*). These data are similar to results obtained
at much higher concentrations.[19a] b) Mass balance diagram for the forma-
tion of various iron oxides showing the equivalence points from (a). The
error was too small to be shown (E1=zero (to 3 decimal points) and
E2= :1.3%). GR=green rust and SWM= schwertmannite.
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showed that the homogeneity of the sample was greatly en-
hanced with respect to both the iron oxide phase (controlled
for magnetite, with removal of undesired iron oxide by-prod-
ucts) and narrowing of the size distribution of magnetite nano-
particles. It therefore appears that Mms6 can control the for-
mation of the specific mineral magnetite, as well as its size.
To study Mms6 further we added purified protein to the re-
action at a concentration of 10 mgmL@1 of reaction solution.
The pH titration profile was recorded at various values of X,
shown in Figure 3a. The R positions of equivalence points E1
and E2 were plotted on the mass-balance diagram to allow
comparison between the control titration and the correspond-
ing Mms6 experiment (Figure 3c).
From these pH data we can see that there is negligible dif-
ference between the titrations at low pH, and thus the R
values of E1 do not alter between the control and Mms6 ex-
periments, with all falling very close to this ideal line for the
formation of schwertmannite, in agreement with previous con-
trol studies.[19a]
Results in the literature have shown that Mms6 is able to
bind ferric ions.[7,8] However, this is not noticeably the case in
this study and as such we propose that Mms6 may only bind
to ferric ions at higher pH, or if there is no competing ferrous
ions, or that the binding to soluble ferric ions is at concentra-
tions too low to detect in this titration. It should be noted that
the methodology used in this study is likely to only detect the
formation and precipitation of solids from solution and is un-
likely to detect the binding of iron ions by Mms6 alone. The
consistency between control and Mms6-mediated RTCP reac-
tions at E1 indicates Mms6 does not alter the balance of iron
species present at low pH.
With Mms6 present, the formation of the second plateau
occurs earlier and at lower pH for X,0.4 (Figure 3a and b).
This shows that Mms6-containing reactions begin to form new
precipitates at a lower pH after the same quantity of base has
been added compared to the control reactions. This indicates
that in the presence of Mms6, Fe2+ and hydroxide ions com-
bine more readily with the ferric oxyhydroxide to generate the
mixed valence iron minerals magnetite and green rust.[19] Here
it should be noted that magnetite precipitates at a lower pH
than green rust [see Eqs. (2) and (3)] , thus comparably more
magnetite is being precipitated at this second plateau in the
Mms6 mediated reactions than the controls for X,0.4, demon-
strating that Mms6 is able to direct the nucleation and forma-
tion of magnetite preferentially. The difference becomes negli-
gible when the reaction is performed under conditions where
the ferric and ferrous iron are equally balanced or ferric ions
predominate (Figure 3a and b).
For each value of X, from the E2 position in the mass-balance
diagram (Figure 3c, Supporting Information Table S1) the rela-
tive amounts of each of the possible minerals (ferrous hydrox-
ide, green rust and magnetite) were calculated (Figure 4a;
note 0.2,X,0.6 as the higher X point is outside this mass bal-
ance mineral regime and shows negligible difference between
control and Mms6 samples). These relative amounts are shown
in Figure 4b (values in Supporting Information Table S2). At
X=0.2 (the most extreme ferrous-rich ratio tested) the control
reaction products are dominated by green rust and ferrous hy-
droxide species (as the excess ferrous ions are precipitated)
with negligibly small quantities of magnetite being produced.
However, at this same X value with the addition of Mms6, ap-
proximately 20% of the mineral species formed is magnetite,
a similar quantity to the green rust, consuming the available
ferric ions. Our data show that Mms6 is acting to promote the
formation of magnetite at lower X values. This magnetite in-
crease is larger in the ferrous iron rich reactions (i.e. , when X is
lower), with the quantity of magnetite coinciding with the pro-
tein free reactions at around X=0.4. Then at higher values of X
there is less effect on the quantity of magnetite formed (as
this is able to occur more readily anyway). However, more
green rust is formed at the expense of ferrous hydroxide (com-
pared to the control), and this is more able to mature and con-
vert to magnetite under these conditions (Figure 4b). Further-
more, the magnetic data follow this trend (Supporting Infor-
mation Figure S3 and Table S3).
Taken together, our analysis indicates that the main role of
Mms6 is to sequester and bind ferrous ions, particularly at the
later, higher (post E1) pH stages where they would normally
Figure 3. a) pH titration profiles for the addition of Mms6 at various values
of X. b) Graph to show how the Mms6 and control pH titrations vary at dif-
ferent X values. Left axis and black closed circles show relative pH difference
at E* (central plateaus), right axis and open blue circles shows difference in
E2. Data show the greatest difference at lower values of X (ferrous-rich solu-
tions). c) Mass-balance obtained from titration data with Mms6. Red circles
show the E1 values for reactions with Mms6: the position is close to the ex-
periments without protein. The red triangles show the E2 values in the pres-
ence of protein. Black open circles are E1 without protein and crosses are E2.
The errors are too small to be shown (E1= zero (to 3 decimal points) and
E2= :1.3%). The positions of various iron oxide minerals are indicated in
the diagram. GR=green rust and SWM= schwertmannite.
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start to precipitate. The result of this activity is that Mms6 pro-
motes the formation of magnetite under unfavourable ferrous-
rich conditions when it is less able to yield magnetite as a prod-
uct in the control reaction (Figure 4b). Mms6 could thus be
considered as acting as a “mineral/ferrous ion buffer” seeming-
ly enhancing the propensity to nucleate magnetite, even when
this does not normally occur, as in the case where X=0.2, and
directing its precipitation towards magnetite rather than other
mixed valence or ferrous salts.
Ferrous and ferric iron interactions with Mms6-derived
peptides
Despite extensive study there is currently no structural infor-
mation on Mms6 or its C-terminal iron-binding domain. We
have attempted protein crystallization and NMR spectroscopy
on the full-length protein but this has proved intractable due
to protein aggregation and disordered structures. However, in
order to obtain structural information relating to metal bind-
ing, the whole protein (particularly the proposed hydrophobic
self-assembly part) is most likely not required. The C-terminal
region is the most acidic and thus proposed to be the iron
binding site. There is also some evidence that the C-terminal
region alone can show some activity in magnetite formation
reactions, suggesting it probably retains the ability to bind
iron ions even when the remaining two thirds of the full
length protein is removed.[12] In order to address the questions
of the metal-binding properties of the protein we have em-
ployed a 2D NMR spectroscopic approach to investigate possi-
ble structure and iron binding characteristics (particularly and
uniquely considering ferrous iron binding) of a 20 amino acid
peptide sequence consisting of the acidic region of Mms6
under physiological pH conditions. We designate the Ac-
KSRDIESAQSDEEVELRDAL-Am peptide as C20Mms6 (N and
C terminus were modified by acetylation and amidation, re-
spectively, to negate possible interactions with the termini
which would not appear in the full-length protein at these resi-
due positions). Crucially the C-terminal region does not have
the same micellar-forming properties as full-length Mms6,
which simplifies its study by NMR spectroscopy.
We performed TOCSY and ROESY NMR experiments on the
C20Mms6 peptide in sodium phosphate buffer at pH 7 (pH of
the species formed at the second plateau where we see Mms6
activity) in order to obtain a complete assignment of the pep-
tide for the backbone plus sidechains as far as Hb or Hg. An as-
signment can be found in Supporting Information Table S4
and a portion of the spectrum can be seen in Figure 5. The 2D
NMR studies of the C20Mms6 peptide sequence do not show
any evidence for a defined structural conformation in the ab-
sence of iron. We did not observe any significant chemical
shift differences from random coil values[22] (largest Ha differ-
ence from expected random coil values is 0.092 ppm, mean
Ha difference is 0.021(:0.028) ppm; complete details can be
found in Supporting Information Figure S4). This indicates that
the peptide adopts an unstructured conformation in solution.
In addition we did not observe any non-sequential NOE peaks
due to through-space interactions between side chains.
The presence of iron ions in NMR experiments severely sup-
presses peak intensities through paramagnetic relaxation en-
hancement (PRE). This mechanism is a result of interaction of
Figure 4. a) Detailed view of the upper part of the mass balance diagram.
Triangles are E2 values of the Mms6 reactions and black crosses are protein-
free E2 values. As an example, black dotted lines represent bisections of the
phase diagram to calculate the quantities of each iron mineral for the
X=0.3 Mms6 data point. b) The percentage of each iron mineral calculated
from the mass balance diagram is shown for each value of X either with or
without Mms6. Dotted boxes= ferrous hydroxide, hashed boxes=green rust
species, and black boxes=magnetite.
Figure 5. A portion of the HN-Ha region for C20Mms6 from TOCSY (blue)
and ROESY (purple) experiments at pH 7.
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the unpaired electrons of iron with the NMR active nuclei. PRE
can be a useful tool in structural biology for identifying resi-
dues of a metalloprotein which are involved in binding para-
magnetic metals,[23] but is undesirable here because it leads to
signals becoming broad and unobservable. Hence we used
low peptide concentrations which allow the addition of ex-
tremely small quantities of iron to keep PREs to a minimum.
This strikes a good balance between maintenance of the signal
level and longer acquisition times. Furthermore, addition of
iron to peptide samples acts to lower the pH which can show
a shift. These can mask the chemical shift changes due to
metal binding. We therefore included in excess a non-chelating
buffer, MES, to strictly regulate the pH during the experiment
and we checked the pH carefully before and after addition of
metals and adjusted it where necessary, to ensure that any dif-
ferences we observed were in fact due to metal binding rather
than pH changes.
Previously reported studies have shown that Mms6 can bind
Fe3+ as well as other metals such as calcium and magnesium,
but not copper, manganese or zinc.[7] Based on this evidence
we screened a panel of metals consisting of Fe2+ , Fe3+ , Ca2+ ,
and Zn2+ . This allowed us to compare metals which C20Mms6
either should bind (Fe3+ , Ca2+) or should not bind (Zn2+) and
to test the binding of the unknown Fe2+ . Considering that
magnetite is composed of an ordered mixture of both ferrous
and ferric ions, and from the insight we have obtained from
the pH titrations, this experiment was designed particularly to
probe Fe2+ interaction and binding as there has been no pre-
vious analysis of Mms6 binding to ferrous iron. Ferrous and
ferric iron chloride were tested in separate NMR experiments
by titrating iron in small increments into the NMR tube until
the signal levels were too small to be detected, indicating the
maximum quantity that could be added. To interpret the
C20Mms6 chemical shifts upon addition of metal ions we ana-
lysed both the shift of the amide proton peaks, Figure 6a, as
well as the mean shift value for the side chain signals, Fig-
ure 6b. As we expected, the addition of zinc to the C20Mms6
peptide gave rise to consistently small shifts along the length
of the peptide chain, indicating no specific or significant bind-
ing to any residues.
Addition of either ferric or calcium ions, both predicted to
bind, did result in a number of significant chemical shift
changes. The most shifted residues are located at the acid-rich
cluster D11–E13 with the largest average sidechain shift re-
corded for ferric binding at the sidechain of glutamic acid E13.
However, the changes were small. Furthermore, losses in signal
intensity due to PREs from Fe3+ were widely distributed along
the peptide sequence, further implying nonspecific binding of
Fe3+ .
The most significant shifts and intensity changes were ob-
served upon the addition of ferrous iron. The magnitudes of
the shifts in this case are up to fivefold greater than those ob-
served for ferric addition. Residues D11, E12, E13, and E15 are
all implicated in binding as well as (more weakly) E6 located
further away on the polypeptide chain. This clearly indicates
that C20Mms6 is able to specifically coordinate Fe2+ , through
the carboxylate side chains of the five key residues mentioned
above, though presumably not all at the same time. The amide
groups of the peptide main chain (Figure 6a) also show signifi-
cant shifts, potentially indicating that the backbone amide of
these residues may be involved in binding the metal ions di-
rectly or that the chemical environments of the amide back-
bones have changed as a result of binding through the side
chain groups. The latter reason seems more likely as it implies
some conformational change of the peptide as it coordinates
ferrous iron with several sidechains simultaneously.
Simulation studies
To complement the experimental study, and gain further in-
sight at the molecular level, a model peptide (DEEV) was sub-
jected to molecular dynamics (MD) simulations using DL_POLY
classic[24] to investigate ferrous iron binding. DEEV is the region
of Mms6 that displays significant metal binding in our NMR ex-
periments. Interactions were explored with 2 ns MD simula-
tions between DEEV and a single ferrous ion placed initially at
one of 12 potential binding sites (Supporting Information Fig-
ure S5). The position of the ferrous ion during each simulation
was tracked relative to the oxygen atoms of the peptide to de-
termine the strength of the interaction and the most likely
binding sites. We found that 16% of the sampled configura-
tions resulted in ferrous binding, defined as the metal ion
being positioned within 3 a of at least one oxygen atom of
the peptide. A more detailed picture of binding was obtained
by considering which of the oxygen atoms within the peptide
were most likely to be involved in ferrous binding. These re-
sults are summarised in Figure 7a.
We find that one of the most favoured sites is the carboxylic
acid sidechain of the second glutamic acid (E13). However, the
Figure 6. Chemical shift changes for C20Mms6 peptide with the addition of
3 equivalents of metals to 50 mm peptide, Fe2+ , Fe3+ , Ca2+ , Zn2+ . Left :
amide protons; right: mean sidechain shifts.
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most significant binding from the simulations is with the main
chain carbonyl, located between the two glutamate (E12–13)
residues, with 56% of the simulations that resulted in ferrous
binding displaying interactions with this carbonyl. Similarly, the
NMR data report large chemical shifts of the amide protons for
both of these flanking glutamate residues, which could be due
to FeII interaction with the peptide backbone of this region.
However, it could also be due to multiple bonds between the
oxygen atoms in the peptide and the ferrous ion. Further anal-
ysis of the MD trajectories when the ferrous ion is bound to
the backbone in the (E12–13) region reveals that in 90% of
these occurrences it is also bound to one or other of the
oxygen atoms in E13 carboxyl group, compared to just 6% of
the configurations where it is bound to the oxygen in the
backbone only. We do not observe significant binding to the
aspartate residue (D11) in our simulations. However, in our sim-
ulation, the peptide adopts a more compact arrangement
upon ferrous binding, with hydrogen bonds present between
the amide protons of the glutamate residues and the amide
carbonyl of the N-terminal capping group (Figure 7b). This re-
arrangement is likely due to the short length of the peptide,
but could indicate that, whilst not participating in ferrous iron
binding directly, these residues may undergo significant move-
ment upon addition of metal ions, leading to the chemical
shift changes seen.
We also observed that when the ferrous ion is replaced with
ferric ion in the simulations, the additional positive charge
makes binding to the peptide more favourable, but also
means iron binding is seen indiscriminately at all the oxygen
sites present. We believe it is likely that the additional selectivi-
ty shown by ferrous ions may explain why larger and more
specific chemical shift changes are detected experimentally in
the ferrous system.
The ferrous–oxygen radial distribution function (RDF; Fig-
ure 8a) effectively provides a summary of the time spent by
the ferrous ion at a particular distance from an oxygen atom
within the peptide and gives us an indication of the stability
and strength of binding (Figure 8b).
The RDF represents the combination of a number of simula-
tions, each searching a different part of configurational space.
Therefore, it is reasonable to interpret the intensity of the RDF
as the probability of a ferrous ion being at a particular distance
from an oxygen atom, making it a good approximation for the
partition function of the system. The RDF can be transformed
into a plot of free energy versus iron–oxygen separation using
the statistical thermodynamic relationship:
A ¼ @RT lnQ ¼ @RT lnðgðrÞÞ
where g(r) is the radial distribution function (Figure 8a). The
RDF will converge to a value of unity at large separations,
meaning the calculated free energy will be zero when the sep-
aration is large and that the calculated values represent the
free energy change in bringing the ferrous ion towards the
peptide to a separation, r (Figure 8b).
Figure 7. Simulated ferrous iron binding to acid-rich DEEV cluster of Mms6.
a) Locations and probability of binding of ferrous iron: red is high probabili-
ty, orange medium, and yellow low. Grey represents areas of no binding.
b) Typical snapshot of peptide binding to ferrous iron (grey sphere). Black
dashed lines are hydrogen bonds, in this example between Fe2+ and both
E12 carbonyl and E13 sidechain, and hydrogen bonds from the N-cap car-
bonyl to both E13 NH and V14 NH.
Figure 8. a) The radial distribution function (RDF) for the ferrous ion interact-
ing with all oxygen atoms in the peptide, and b) transformation as a free-
energy profile of iron binding as a function of distance from oxygen sites at
300 K.
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Inspection of Figure 8a shows that the binding to the pep-
tide occurs over a narrow range of separations between 2.55
and 3.25 a (optimum bond distance 2.85 a). The intensity of
this peak, and the narrow range of bond distances it covers,
suggests that when iron is bound it is held relatively strongly.
The fact that the RDF drops close to zero between the first
and second peak illustrates that once a ferrous ion binds to
a particular site, it will remain bound to the peptide for a signif-
icant time in most cases.
These observations are clearer when the data are plotted as
an energy profile (Figure 8b). A deep energy well is evident
close to the surface which corresponds to a binding energy of
@6.7 kJmol@1 (@2.7RT). This is sufficiently large that it could
not be overcome by the kinetic energy possessed by the
atoms. Therefore, once a ferrous iron has entered the well it is
unlikely to leave during the simulation. To leave the adsorption
layer, the ion must also cross the energy barrier at 3.5 a sepa-
ration, giving a total barrier to desorption of 10.2 kJmol@1
(4.0RT).
Whilst indicative of the nature of binding, it must be noted
that Figure 8 is an average of the behaviour of a ferrous ion in
multiple simulations and does not give any indication of how
the energy profile differs at sites where iron binding is known
to be favoured and where it is not observed.
Such insight can be gained by plotting the RDF (and associ-
ated free-energy profile) for the individual interactions be-
tween a particular oxygen and the ferrous ion (Supporting In-
formation Figures S7 and S8). At residue E13 and the bridging
carbonyl oxygen between E12 and E13 sites, the binding
energy is significantly higher, between @9 and @11 kJmol@1
(or 3.5 to 4.5RT), with the additional energy required for the
ferrous ion to leave the adsorption layer approximately
4 kJmol@1 (&14 kJmol@1). This suggests that once an ion
enters these binding sites it will not leave for the duration of
the MD simulation and that binding should be observable on
an experimental timescale. The sites in D11 and E12, where
limited iron binding is seen in the MD simulations, display
a binding energy of approximately @4 kJmol@1. This is close to
the kinetic energy possessed by the atoms in ambient condi-
tions. An additional energy barrier must still be crossed for the
ion to completely leave the binding site but is still of an order
that such desorption is possible and hence why only limited
binding is observed in the MD simulations. When extended to
larger time scales, this would represent a system where contin-
uous exchange between binding and desorption would be
possible, especially when concentration effects, not present in
our MD simulations, are taken into account.
Similar calculations were performed using Fe3+ instead of
Fe2+ . The additional charge on the iron made the overall bind-
ing energy to this negatively charged peptide more favour-
able. However, it is significant that binding was less specific to
E12/E13.
Discussion and Conclusions
Analysing the effect of Mms6 in situ through pH measure-
ments throughout the magnetite-formation process has en-
abled us to obtain an insight into the protein’s function and in
particular, at what stage in the reaction it exerts its effect. We
see no influence of the protein in the early stages of the reac-
tion at low pH at the point where ferric oxyhydroxide minerals
are formed, consistent with the theoretical isoelectric point of
4.2 of the acidic iron binding region of the protein. It is from
pH 5 and upwards that we see Mms6 affecting the formation
of the minerals, at the point that ferrous ions begin to precipi-
tate out of solution and mixed valence iron minerals are
formed. From our data it appears that Mms6 promotes the for-
mation of magnetite under ferrous-rich conditions, even in
conditions in which magnetite does not readily form. All previ-
ous studies on the iron binding activity of Mms6 have focused
on ferric-ion binding of the acidic C-terminal region[7,8] and
often at low pH. From our study it seems Mms6 is more likely
to interact predominantly with ferrous ions at pH>5. In this
context we performed an NMR metal-binding experiment
under these conditions and we saw that Mms6 does indeed
show specific and significant interactions with ferrous ions
compared to both positive and negative control metals, includ-
ing ferric ions. The residues responsible for binding metals
vary for ferrous and ferric ions, but the DEEVE cluster was
found to have the biggest shift for both iron ions, with the
double EE site having the prominent shift for ferric ions and all
the acidic residues of the whole DEEVE region significantly
shifted (up to 5V >Fe3+) in the presence of ferrous ions.
The interaction of this smaller peptide of interest with fer-
rous and ferric ions was thus modelled by atomistic simulation
in order to further understand the binding event. This indicat-
ed that the acidic residues may bind the ferrous iron not only
through their carboxylate sidechain but also through the pep-
tide carbonyls. The MD calculations also show that multiden-
tate binding is preferred, especially for ferrous ions, and that
bidentate binding of Fe2+ to E12 carbonyl and E13 carboxylate
is particularly frequent. Ferric ions show binding, but unspecif-
ically across the acidic amino acids.
As the pH is raised, and particularly at high ratios of ferrous
to ferric ions, the initially formed ferric oxyhydroxide precipi-
tate must re-dissolve and reform into a different crystalline
structure in order to incorporate ferrous ions and form mag-
netite. Our data suggest that Mms6 is facilitating this process.
We therefore propose an in vitro mechanism in which Mms6
displays little activity below pH 4–5. Above this, Mms6 specif-
ically sequesters and binds ferrous ions. We also propose that
the Mms6’s known affinity for ferric ions promotes the dissolu-
tion of the unstable ferric precursors to sequester ferric ions as
well. We have shown here that the role of Mms6 is to promote
the formation of magnetite at high ferrous ratios, which are
conditions where magnetite is formed poorly if at all in the ab-
sence of Mms6. We therefore propose that Mms6 not only
helps to dissolve undesired precipitates, such as ferric oxyhy-
droxide, but helps the formation of magnetite by acting as
a nucleation protein.
Mms6 is known to self-aggregate[10] and it is already pro-
posed that Mms6 assembles to form an acidic, charged, C-ter-
minal surface to bind multiple iron ions.[8,25] The self-assembly
of Mms6 could space these acidic residues to bind both fer-
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rous and ferric ions in a magnetite crystallographic geometry
to template and promote the initial formation of magnetite
over other iron minerals by lowering the free energy for forma-
tion of magnetite.
Relating the reactions occurring in solution in this experi-
ment to those found in vivo is challenging. Mms6 is associated
with the magnetosome membrane, so the C-terminal acidic
surface of an Mms6 assembly will differ in its in vitro micelle
structure compared to the arrangement in the internal lumen
of the magnetosome. In the magnetosome there are transport-
ers that transport iron ions into the magnetosome.[26] All cur-
rent knowledge points to the transport of ferrous ions only,
with partial oxidation of some of the ferrous ions to generate
the ratio required for magnetite formation.[26] Furthermore,
ferrous transporters are antiporters meaning they bring ferrous
iron in as they take protons out. This will help to regulate
the internal pH, but the precise pH of this environment is also
not currently known. Additionally, due to the iron transport
system it is highly unlikely that there will be SO4
2@ counter-
ions, ruling out the formation of schwertmannite and green-
rust phases.
However, similarities between the two systems can be
drawn to predict the action of Mms6 in the magnetosome.
While the pH of the interior of the magnetosome has not yet
been determined, it must at some point be high enough to
enable magnetite to crystallise (+pH 7), and we have estab-
lished in this study that Mms6 is active in these conditions. In
the natural system we assume some of the ferrous ions are
converted to ferric (through the action of oxidase enzymes),
and thus a ferric mineral will precipitate (due to its chemical in-
solubility at pH+2.5). There have been several reports of such
ferric precursors,[27] and while our suggested mechanism relies
on dissolution of this precursor, its exact form is immaterial, be
it schwertmannite (in vitro) or ferrihydrite (in vivo). Interesting-
ly, Mms6 activity is greatest in ferrous-rich conditions, which is
likely to be the predominant state in magnetosomes if it is
confirmed that iron transport is of ferrous iron. It is therefore
likely that in vivo conditions in the magnetosome are similar
to our in vitro conditions with respect to possible pH, ferric
precursors in a ferrous-ion-rich solution, and the protein’s abili-
ty to form a self-assembled charged surface capable of seques-
tering ferrous and ferric iron in the exact proportions to pro-
mote the crystallization of magnetite.
Therefore we propose, both in vitro and in vivo, that Mms6
is a magnetite nucleation protein, able to bind both ferric and
specifically ferrous iron to initiate the process of templating
the magnetite crystal.
Experimental Section
Ferrous and ferric sulfate were purchased from Sigma–Aldrich and
used without further purification. ICP-AES was used to check the
hydration level of both compounds prior to each set of experi-
ments.
Peptide C20Mms6 KSRDIESAQSDEEVELRDAL, featuring an acetylat-
ed N terminus and an amidated C terminus, was purchased from
Genscript (USA). The peptide was dissolved in and dialysed, over-
night, against a chosen buffer in a dialysis cassette with a MWCO
of 1 kDa, to remove trace salts. MES and NaH3PO4 were purchased
from Sigma–Aldrich and used without further purification.
Biochemical methods
The mms6 sequence from Magnetospirillum magneticum AMB-
1 was introduced into a pTTQ18-based expression vector by cohe-
sive-end cloning with the resulting plasmid, pHis8mms6, encoding
N-terminally octahistidine tagged Mms6. The protein was pro-
duced in E. coli BL21 star (DE3) cells (Invitrogen) harbouring
a pRARE (Merck) plasmid to compensate for codon bias in the
mms6 sequence. Cells were cultured in autoinducing Superbroth
(Formedium) at 37 8C with shaking for 24 h in the presence of car-
benicillin and chloramphenicol to select for the pHis8mms6 and
pRARE plasmids, respectively. Cells were lysed by sonication in
25 mm Tris pH 7.4, 100 mm NaCl. The insoluble material, containing
the His8–Mms6 inclusion bodies, was collected by centrifugation at
16000g and resuspended in 6m guanidine hydrochloride, 25 mm
Tris pH 7.4 to solubilise the proteins. Further centrifugation at
16000g was performed to remove any material not solubilised by
the guanidine treatment. The supernatant was mixed with nickel
charged nitrilotriacetic acid (NTA) resin (Amintra resin, Expedeon)
to allow binding of the histidine tagged Mms6. The resin was sub-
sequently packed into a gravity flow column and washed exten-
sively with wash buffer (6m guanidine hydrochloride, 25 mm Tris
pH 7.4, 10 mm imidazole) before elution of the bound protein in
300 mm imidazole-supplemented wash buffer. The eluted protein
was refolded by rapidly diluting into a large volume of refolding
buffer (500 mm NaCl, 25 mm tris pH 7.4) before being concentrated
using a 10 kDa molecular weight cut-off centrifugal concentrator
(Sartorius). The concentrated material was subjected to centrifuga-
tion to remove any small amounts of precipitated protein before
dialysis against 500 mm NaCl using a 3.5 kDa molecular weight
cut-off slide-a-lyser (Thermo Scientific). The refolded His8–Mms6
was quantified by absorbance at 280 nm and stored at 193 K.
NMR spectroscopy experiments and analysis
For NMR studies all samples were prepared in a 90% H2O/10%
D2O solvent mixture. NMR spectroscopy was performed on
a Bruker Avance DRX instrument at 600 MHz, equipped with
a triple resonance (1H-13C/15N-2H) cryoprobe with z-gradient, at
25 8C. TOCSY experiments were carried out with a spin lock power
of 8.3 kHz for 45 ms, and ROESY experiments with a spin-lock
power of 2.27 kHz with a 200 ms mixing time. Solvent suppression
was achieved with a 3–9–19 pulse sequence with presaturation
during the relaxation delay of 1.5 s for the TOCSY experiment, and
with excitation sculpting with gradients for the ROESY experiment.
For sequential assignment, 1 mm C20Mms6 was prepared in
20 mm NaH3PO4 buffer at pH 7. 3-(Trimethylsilyl)-2,2’,3,3’-[D4]-propi-
onate (TSP) was added as a standard (0.0 ppm). For metal binding
studies, 50 mm C20Mms6 was dialysed extensively against MES
buffer (50 mm) at pH 5.66:0.02. Metals were dissolved in the
same buffer, and added directly to the NMR tube stepwise until
the metal concentration was 150 mm. At each addition, the pH was
checked and adjusted to 5.66:0.02 if necessary.
Co-precipitation of magnetite
Ultrapure (MilliQ) water was degassed under vacuum and sparged
with nitrogen for at least 1 h to remove dissolved oxygen. An ali-
quot (20 mL) of this water was added to a three-necked glass flask.
The solution is isolated from the air by continuous sparging with
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nitrogen. This is also used to mix the solution. Fe salts were mea-
sured to 0.1 mg accuracy and stored in a small plastic tube. Initially
Fe3+ was added to the solution by removing 1 mL of the solution
and dissolving the Fe salt in the tube. This was then added to the
solution with a glass pipette. Fe2+ was then added in the same
way. Each set of experiments varies the X parameter from 0.2 to
0.5. One batch of nitrogen sparged 1m NaOH solution was used
per set of experiments to ensure consistency.
A Mettler Toledo 7 Multi-pH meter with Micro-Pro probe was im-
mersed in the solution. Data were logged on a computer via serial
port communication at three second intervals for the duration of
the experiment. The NaOH injection needle was pre-primed before
the start of the experiment. This solution was added continuously
to the reaction flask at a rate of 50 mLmin@1 via a syringe pump
driver.
Simulation studies
The molecular dynamics simulations were based on a molecular
mechanics approach where the intra- and intermolecular interac-
tions within the peptide were described using the generalised
Amber force field (GAFF)[28] which also incorporates a version of
the TIP3P water molecule.[29] Partial charges on the peptide were
determined using semi-empirical calculations at the AM1 level of
theory.[30] A total of 24 production calculations were performed (2
different ions with 12 starting configurations) where the peptide
was placed at the centre of a 40 aV40 aV40 a box which con-
tained approximately 2000 water molecules. In all cases the 3D
boundary conditions were applied within the isobaric isothermal
NPT ensemble which allows the sizes of the simulation cell to
change during simulation. The temperature and pressure were
maintained at 300 K and 105 Pa using a Nose–Hoover thermostat
and barostat with a period of 0.1 and 0.5 ps.[31] The trajectories
were generated using the Verlet leapfrog algorithm with a time
step of 1 fs.[32]
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